Tag: Lombard Medical

Altura: Simplicity and evolutionary design | Aorfix: Flexibility and conformability in...

In this supplement: -Altura has the potential to significantly improve many facets of EVAR performance -Early Altura data show “very encouraging” safety and effectiveness...

Lombard Medical appoints Jonathan Hornsby as vice president of sales and...

Lombard Medical has announced the appointment of Jonathan Hornsby as vice president of sales and marketing, effective immediately. Jonathan Hornsby brings over 20 years of...

Lombard Medical announces restructuring and strategy to achieve profitability

Lombard Medical has announced completion of a restructuring following the implementation of its new strategy to focus sales efforts in the UK, Japan and...

Lombard issues recall of Altura devices with problem in delivery system

On 30 June 2017, Lombard Medical notified the UK Medicines and Health products Regulatory Agency (MHRA) about problems with the Altura stent graft device....

First patient enrolled and treated in the Altura stent graft ALTITUDE...

Lombard Medical has now enrolled and treated the first patient in its global registry to evaluate its Altura endograft system. The ALTITUDE registry (Altura impact on the treatment of abdominal...

Lombard Medical’s endovascular product portfolio presented at 2017 Charing Cross Symposium

Lombard Medical’s portfolio of endovascular stent graft systems, Altura and Aorfix, were featured in scientific presentations at the 39th annual Charing Cross International Symposium (CX;...

Lombard Medical appoints new CEO

Kurt Lemvigh has been appointed as its new chief executive officer of Lombard Medical, effective immediately. Lemvigh is a veteran medical device executive with over...

Lombard Medical CEO steps down

Simon Hubbert has stepped down from his position as chief executive officer on 18 April after serving in the role for more than six years. A...

Lombard Medical and MicroPort Scientific Corporation finalise strategic partnership agreements

Lombard Medical and MicroPort Scientific Corporation have finalised the definitive agreements to their strategic partnership first announced on 19 December 2016. The partnership will allow Lombard to accelerate...
Lombard Intelliflex

Lombard Medical gets Japanese approval for IntelliFlex LP delivery system

Lombard Medical has announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex low-profile (LP) delivery system for the Aorfix...

Lombard Medical and MicroPort announce strategic partnership and investment agreement

Lombard Medical and MicroPort Scientific Corporation have announced a strategic partnership and a significant infusion of capital into Lombard Medical by MicroPort. According to...

Five-year data confirms sustained performance of Aorfix in challenging anatomies

Lombard Medical has announced positive long-term data providing confirmation of sustained performance for its Aorfix endovascular stent graft system in the most challenging anatomies.  The...

Multicentre early experience on Altura presented at the VEITHsymposium

Lombard Medical has announced that its Altura endovascular stent graft system was featured in a scientific presentation at the VEITHsymposium in New York, USA, on 17...

Lombard Medical closes US operations

Lombard Medical announced on 22 August 2016 “a significant operational restructuring and the exploration of strategic alternatives to enhance shareholder value” with the closure...

European launch of Altura expanded

Lombard Medical has announced that it has expanded the European launch of its new Altura endovascular stent graft system to The Netherlands and Spain....

Lombard Medical to conduct global registry of Altura stent AAA patients

Lombard Medical is to conduct a 1,000 patient global registry to evaluate its new Altura Endograft System. The ALTITUDE registry (AlturaImpact on the Treatment...